03 Dec 2024 Minimizing harms of tight glycemic control in older people with type 2 diabetes
This webinar has already taken place. Scroll down to view the video recording.
—
In this TI Best Evidence webinar, Dr. Wade Thompson reviewed evidence and key messages from the recent Therapeutics Letter and Portrait on management of type 2 diabetes for older adults. Click the DOWNLOAD button to view or download a copy of the slide deck in PDF format.
—
TITLE: Minimizing harms of tight glycemic control in older people with type 2 diabetes
WHEN: Tuesday, December 3rd, 2024 at 12:00 PM PST [convert to your local time]
WHERE: free online webinar.
SPEAKER: Dr. Wade Thompson, Assistant Professor, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia.
CME CREDITS: MainPro+/MOC Section 1 credits: 1.0. Those who registered, attended the webinar and completed the evaluation will receive their certificate.
LEARNING OBJECTIVES (by the end of this session, participants will be able to):
- describe considerations for treating type 2 diabetes among older adults;
- apply them in their practice.
About the topic: As people age, they are more likely to experience side effects from drugs. People with multiple health problems who take many medications are at even higher risk of harm from side effects. For diabetes medications, one of the most important side effects is low blood sugar. Sulfonylureas and insulins are the drugs most likely to cause low blood sugar. Therapeutics Letter 151 (September-October 2024) concluded that for most older adults (65 years or older) with type 2 diabetes who have an A1c below 7%, sulfonylureas or insulin do more harm than good, and this webinar will offer a ‘behind the scenes’ view on the evidence for this. The Therapeutics Initiative also produced individual prescribing Portraits on the topic of prescribing diabetes medications to older adults with type 2 diabetes, which were released online to clinicians in BC who are registered for the Portrait program. Eligible clinicians (primary care physicians and nurse practitioners) were randomized to have access to the Portrait in two groups, an early group of clinicians were granted online access to Portrait in January 2024 and a delayed group were granted access in October 2024. You can view a sample Portrait here. The webinar aimed to demonstrate the usefulness of the Portrait program. Participants also had an opportunity to ask questions, discuss the current evidence, and explore ways to improve their own practice.
About the speaker: Dr. Wade Thompson, PharmD, MSc, PhD is an Assistant Professor in the Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, and the Lead of the Therapeutics Initiative Evidence Synthesis Unit. Wade is a pharmacist and researcher working to ensure older persons are taking medications that are necessary, effective, safe, and consistent with their healthcare goals and treatment preferences. This primarily involves developing and evaluating strategies to stop medications when they are no longer a good fit (“deprescribing”). Wade approaches deprescribing and polypharmacy management research with a multi-methods approach, incorporating qualitative methods, pharmacoepidemiological methods, knowledge translation, and implementation science. He is also an investigator with the deprescribing.org initiative. Wade has worked clinically as a pharmacist in long-term care, geriatric outpatient clinics, and primary care clinics.
No Comments